News

Featured Articles

Latest News

March 17, 2008
Excerpt Of Interview With Stephen Weiss On Auction Rate Securities Class Actions

Seeger Weiss’ founding partner Stephen Weiss was interviewed by a Bloomberg news staff writer to asses the current state of the Auction-Rate security class actions, pending in various courts. An excerpt of the article follows: “…We do not bring cases unless we think there is a very good basis,” said Jerome Congress, a partner with […]

Read More
March 3, 2008
Seeger Weiss Reports Enrollment of 93% of Eligible Plaintiffs in VIOXX Settlement

Seeger Weiss LLP, announced today that 93 percent of eligible individuals have enrolled in the nationwide VIOXX settlement program first announced last November. Under the program, Merck has set aside $4.85 billion to compensate those claimants who suffered a heart attack, ischemic stroke, or sudden cardiac death while taking the drug. Seeger Weiss founding partner, […]

Read More
November 9, 2007
$4.85 Billion Vioxx Heart Attach & Stroke Settlement

Christopher A. Seeger, Esq. Served on Vioxx Negotiating Committee on Behalf of Thousands of Plaintiffs Nationwide Seeger Weiss LLP, announces that founding member Christopher A. Seeger along with co-counsel on the Vioxx Negotiating Committee have obtained a $4.85 billion Global Resolution with Merck & Co. (NYSE: MRK) for heart attack and stroke claims related to […]

Read More
August 16, 2007
Seeger Weiss LLP Announces Class Action Lawsuit Against RAIT Financial Trust

Seeger Weiss LLP announces that it filed a class action lawsuit today in the United States District Court For The Eastern District Of Pennsylvania on behalf of purchasers of RAIT Financial Trust (“RAIT” or the “Company”) (NYSE: RAS) common stock in the open market between January 10, 2007 to July 31, 2007, inclusive (the “Class […]

Read More
March 12, 2007
Seeger Weiss secures a $47.5 million verdict against Merck in Vioxx trial

A jury in Atlantic County, N.J. today returned verdicts, awarding $20 million in compensatory damages and $27.5 million in punitive damages to plaintiff Frederick ‘Mike’ Humeston and his wife Mary against defendant Merck & Co. (NYSE: MRK) in the Vioxx-related personal injury trial entitled, Humeston v. Merck, as reported by the plaintiffs’ trial counsel, Seeger […]

Read More